Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases
Most chronic liver diseases (CLDs) are characterized by inflammatory processes with aberrant expressions of various pro- and anti-inflammatory mediators in the liver. These mediators are the driving force of many inflammatory liver disorders, which often result in fibrosis, cirrhosis, and liver tumo...
Main Authors: | Ting Liu, Yu Zhou, Kwang Suk Ko, Heping Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/276850 |
Similar Items
-
Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases
by: Priya Handa, et al.
Published: (2014-01-01) -
c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease
by: Kang Zheng, et al.
Published: (2017-04-01) -
Mediators of Inflammation: Inflammation in Cancer, Chronic Diseases, and Wound Healing
by: Caigan Du, et al.
Published: (2015-01-01) -
A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors
by: Zhen Li, et al.
Published: (2013-03-01) -
Interaction between the proteins c-MYC and MLH1
by: Robinson, Helen
Published: (2004)